About
Microbiome-based Products for Combination Therapy with Immuno-oncology
Ella Therapeutics is developing microbiome-based products for combination therapy with immuno-oncology. Ella Therapeutics' mission is to overcome immunotherapy resistance in cancer patients through alteration of the gut microbiome via engineered bacteria or a live biotherapeutic product. The company's platform is for all major cancer indications and was developed with the aim of saving lives that were otherwise lost due to patients' bodies' resistance to medicine.
Identity
| Name | Ella Therapeutics |
|---|---|
| Slug | ella-therapeutics |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LGxgoQKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jul 2022 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat Gan |
| HQ address | Tuval St 40, Ramat Gan, Israel |
Web & social
| Website | https://www.ellatherapeutics.com/ |
|---|---|
| https://www.linkedin.com/company/42173725 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
oncologycancermicrobiomeimmunotherapybiopharmaceuticalbioinformaticsbiotechnology
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}